Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 2
2015 2
2016 2
2017 4
2018 2
2019 2
2020 3
2021 1
2022 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
In vivo degradation and endothelialization of an iron bioresorbable scaffold.
Lin W, Zhang H, Zhang W, Qi H, Zhang G, Qian J, Li X, Qin L, Li H, Wang X, Qiu H, Shi X, Zheng W, Zhang D, Gao R, Ding J. Lin W, et al. Bioact Mater. 2020 Oct 12;6(4):1028-1039. doi: 10.1016/j.bioactmat.2020.09.020. eCollection 2021 Apr. Bioact Mater. 2020. PMID: 33102944 Free PMC article.
The efficacy as a coronary stent of this new bioresorbable scaffold was compared with that of a permanent metal stent with the name of trade mark Xience, which has been widely used in clinic. The endothelial coverage on IBS was found to be greater than on Xience aft …
The efficacy as a coronary stent of this new bioresorbable scaffold was compared with that of a permanent metal stent with the name of trade …
The XIENCE nano everolimus eluting coronary stent system for the treatment of small coronary arteries: the SPIRIT Small Vessel trial.
Cannon LA, Simon DI, Kereiakes D, Jones J, Mehran R, Kusano H, Zhang Z, Lombardi W, James Fleischhauer F, Costa MA. Cannon LA, et al. Catheter Cardiovasc Interv. 2012 Oct 1;80(4):546-53. doi: 10.1002/ccd.23397. Epub 2012 Jan 12. Catheter Cardiovasc Interv. 2012. PMID: 22121027 Clinical Trial.
OBJECTIVES: The SPIRIT Small Vessel (SV) was designed to evaluate the safety and effectiveness of the 2.25-mm XIENCE V everolimus eluting coronary stent system (EECSS), known as the XIENCE nano EECSS, in subjects with SVs and ischemic heart disease. BACKGROUND: The …
OBJECTIVES: The SPIRIT Small Vessel (SV) was designed to evaluate the safety and effectiveness of the 2.25-mm XIENCE V everolimus elu …
Evaluation of Mechanical Performances of Stents with 38 mm Length in Long Lesion.
Yue X, Guo J, Zhang J, Cao C, Zhang Z, Shen D, Tang J, Zhang J. Yue X, et al. Biomed Res Int. 2020 Feb 27;2020:2594161. doi: 10.1155/2020/2594161. eCollection 2020. Biomed Res Int. 2020. PMID: 32190656 Free PMC article.
The ratio of stent diameter reduction from both XIENCE Xpedition and SYNERGY was less than 3% with no statistical difference. ...The ratio of stent diameter reduction from both XIENCE Xpedition and SYNERGY was less than 3% with no statistical difference. ...
The ratio of stent diameter reduction from both XIENCE Xpedition and SYNERGY was less than 3% with no statistical difference. ...The …
Procedural Characteristics of Intravascular Ultrasound-Guided Percutaneous Coronary Intervention and Their Clinical Implications.
Lee SY, Zhang JJ, Mintz GS, Hong SJ, Ahn CM, Kim JS, Kim BK, Ko YG, Choi D, Jang Y, Kan J, Pan T, Gao X, Ge Z, Chen SL, Hong MK. Lee SY, et al. J Am Heart Assoc. 2022 Jul 19;11(14):e025258. doi: 10.1161/JAHA.122.025258. Epub 2022 Jul 15. J Am Heart Assoc. 2022. PMID: 35861828 Free PMC article.
Methods and Results This was a cohort study using patient-level data from the IVUS-XPL (Impact of Intravascular Ultrasound Guidance on the Outcomes of Xience Prime Stents in Long Lesions) and ULTIMATE (Intravascular Ultrasound Guided Drug Eluting Stents Implantation in All …
Methods and Results This was a cohort study using patient-level data from the IVUS-XPL (Impact of Intravascular Ultrasound Guidance on the O …
Improved 3-Year Cardiac Survival After IVUS-Guided Long DES Implantation: A Patient-Level Analysis From 2 Randomized Trials.
Hong SJ, Zhang JJ, Mintz GS, Ahn CM, Kim JS, Kim BK, Ko YG, Choi D, Jang Y, Kan J, Pan T, Gao X, Ge Z, Chen SL, Hong MK. Hong SJ, et al. JACC Cardiovasc Interv. 2022 Jan 24;15(2):208-216. doi: 10.1016/j.jcin.2021.10.020. JACC Cardiovasc Interv. 2022. PMID: 35057991 Free article.
METHODS: We pooled the data of 2 randomized trials (IVUS-XPL [Impact of Intravascular Ultrasound Guidance on the Outcomes of Xience Prime Stents in Long Lesions] and ULTIMATE [Intravascular Ultrasound Guided Drug Eluting Stents Implantation in All-Comers Coronary Lesions]) …
METHODS: We pooled the data of 2 randomized trials (IVUS-XPL [Impact of Intravascular Ultrasound Guidance on the Outcomes of Xience P …
Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease.
Ellis SG, Kereiakes DJ, Metzger DC, Caputo RP, Rizik DG, Teirstein PS, Litt MR, Kini A, Kabour A, Marx SO, Popma JJ, McGreevy R, Zhang Z, Simonton C, Stone GW; ABSORB III Investigators. Ellis SG, et al. N Engl J Med. 2015 Nov 12;373(20):1905-15. doi: 10.1056/NEJMoa1509038. Epub 2015 Oct 12. N Engl J Med. 2015. PMID: 26457558 Free article. Clinical Trial.
RESULTS: Target-lesion failure at 1 year occurred in 7.8% of patients in the Absorb group and in 6.1% of patients in the Xience group (difference, 1.7 percentage points; 95% confidence interval, -0.5 to 3.9; P=0.007 for noninferiority and P=0.16 for superiority). There was …
RESULTS: Target-lesion failure at 1 year occurred in 7.8% of patients in the Absorb group and in 6.1% of patients in the Xience group …
An abluminal biodegradable polymer sirolimus-eluting stent versus a durable polymer everolimus-eluting stent in patients undergoing coronary revascularization: 3-year clinical outcomes of a randomized non-inferiority trial.
Zhang H, Zhang X, Yin Y, Zhou C, Deng W, Zhang J, Hou W, Lu S, Song C, Cui X, Wang S, Yang F, Liu G, Duan C, Ge J. Zhang H, et al. Sci Rep. 2019 Dec 6;9(1):18549. doi: 10.1038/s41598-019-54964-8. Sci Rep. 2019. PMID: 31811206 Free PMC article. Clinical Trial.
The trial was designed to compare the efficacy and safety of the Cordimax stent with the Xience V stent in patients undergoing coronary revascularization. ...In conclusion, safety and efficacy outcomes of Cordimax stent were non-inferior to the Xience V stent 3 year …
The trial was designed to compare the efficacy and safety of the Cordimax stent with the Xience V stent in patients undergoing corona …
Is Routine Postdilation During Angiography-Guided Stent Implantation as Good as Intravascular Ultrasound Guidance?: An Analysis Using Data From IVUS-XPL and ULTIMATE.
Lee YJ, Zhang JJ, Mintz GS, Hong SJ, Ahn CM, Kim JS, Kim BK, Ko YG, Choi D, Jang Y, Kan J, Pan T, Gao X, Ge Z, Chen SL, Hong MK. Lee YJ, et al. Circ Cardiovasc Interv. 2022 Jan;15(1):e011366. doi: 10.1161/CIRCINTERVENTIONS.121.011366. Epub 2022 Jan 18. Circ Cardiovasc Interv. 2022. PMID: 35041452
METHODS: From the pooled data of 2 randomized trials, IVUS-XPL (Impact of Intravascular Ultrasound Guidance on the Outcomes of Xience Prime Stents in Long Lesions) and ULTIMATE (Intravascular Ultrasound Guided Drug Eluting Stents Implantation in All-Comers Coronary Lesions …
METHODS: From the pooled data of 2 randomized trials, IVUS-XPL (Impact of Intravascular Ultrasound Guidance on the Outcomes of Xience …
Mortality After Repeat Revascularization Following PCI or CABG for Left Main Disease: The EXCEL Trial.
Giustino G, Serruys PW, Sabik JF 3rd, Mehran R, Maehara A, Puskas JD, Simonton CA, Lembo NJ, Kandzari DE, Morice MC, Taggart DP, Gershlick AH, Ragosta M 3rd, Kron IL, Liu Y, Zhang Z, McAndrew T, Dressler O, Généreux P, Ben-Yehuda O, Pocock SJ, Kappetein AP, Stone GW. Giustino G, et al. JACC Cardiovasc Interv. 2020 Feb 10;13(3):375-387. doi: 10.1016/j.jcin.2019.09.019. Epub 2020 Jan 15. JACC Cardiovasc Interv. 2020. PMID: 31954680 Free article. Clinical Trial.
METHODS: All patients with LMCAD and site-assessed low or intermediate SYNTAX (Synergy Between PCI With Taxus and Cardiac Surgery) scores randomized to PCI (n = 948) or CABG (n = 957) in the EXCEL (Evaluation of XIENCE Versus Coronary Artery Bypass Surgery for Effectivenes …
METHODS: All patients with LMCAD and site-assessed low or intermediate SYNTAX (Synergy Between PCI With Taxus and Cardiac Surgery) scores ra …
Safety and efficacy of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent.
Zhu J, Liu H, Cui H, Tang Z, Song C, Zhang R. Zhu J, et al. J Mater Sci Mater Med. 2017 Mar;28(3):54. doi: 10.1007/s10856-017-5864-0. Epub 2017 Feb 14. J Mater Sci Mater Med. 2017. PMID: 28197826
The in vivo efficacy of AGF-BP-SES was compared with that of Xience PRIME() stent. The results showed that AGF-BP-SES exhibited mechanical properties similar to traditional DES, including the rebound ratio of radial contraction/direction, rebound ratio of axial contraction …
The in vivo efficacy of AGF-BP-SES was compared with that of Xience PRIME() stent. The results showed that AGF-BP-SES exhibited mecha …
20 results